Cargando…

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Neurogranin (Ng) and visinin-like protein 1 (VILIP-1) are promising candidates for Alzheimer’s Disease (AD) biomarkers closely related to synaptic and neuronal degeneration. Both proteins are involved in calcium-mediated pathways. The meta-analysis was performed in random effects based on the ratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dulewicz, Maciej, Kulczyńska-Przybik, Agnieszka, Mroczko, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664397/ https://www.ncbi.nlm.nih.gov/pubmed/33172069 http://dx.doi.org/10.3390/ijms21218335

Ejemplares similares

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Biochemical Markers in Alzheimer’s Disease
por: Rabbito, Alessandro, et al.
Publicado: (2020)

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2023)

Biomarkers of Activity-Dependent Plasticity and Persistent Enhancement of Synaptic Transmission in Alzheimer Disease: A Review of the Current Status
por: Warpechowski, Marcin, et al.
Publicado: (2023)

Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
por: Zajkowska, Monika, et al.
Publicado: (2021)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
por: Muszyński, Paweł, et al.
Publicado: (2017)

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
por: Kulikowska, Joanna, et al.
Publicado: (2021)

The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease—old wine in new bottles
por: Braunewell, Karl H.
Publicado: (2012)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
por: Sulik, Artur, et al.
Publicado: (2022)

Comparison of VILIP-1 and VILIP-3 Binding to Phospholipid Monolayers
por: Rebaud, Samuel, et al.
Publicado: (2014)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020)

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021)

Investigating the Role of Serum and Plasma IL-6, IL-8, IL-10, TNF-alpha, CRP, and S100B Concentrations in Obstructive Sleep Apnea Diagnosis
por: Fiedorczuk, Piotr, et al.
Publicado: (2023)

The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
por: Portelius, Erik, et al.
Publicado: (2018)

The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023)

Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases
por: Want, Andrew, et al.
Publicado: (2023)

APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease
por: Wang, Lijun, et al.
Publicado: (2020)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
por: Wellington, Henrietta, et al.
Publicado: (2018)

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)

Neurogranin Regulates Metaplasticity
por: Zhong, Ling, et al.
Publicado: (2020)

Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex
por: Sun, Xiaoyan, et al.
Publicado: (2021)

Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress
por: Gui, Jingang, et al.
Publicado: (2007)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_apa3dj4033sh2remc682mvltrb